INXB

Inhibrx Biosciences, Inc. INXB

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode INXB SLRN CBLI MACK CRGX CATB SPPI CELU TCRT THRD
6M 13.94 % -27.94 % 0.00 % 14.39 % 17.63 % 0.00 % 31.75 % 27.70 % 10.71 % 53.71 %
YTD 13.94 % -31.21 % 0.00 % 13.79 % -70.30 % 0.00 % 167.97 % -14.09 % 33.76 % -51.27 %
1Y 13.94 % -42.96 % 252.18 % 21.55 % -81.53 % 0.00 % -10.87 % 11.83 % 27.29 % -60.15 %
3Y -90.67 % -87.39 % 56.93 % 136.64 % -69.24 % 0.00 % -75.65 % -91.89 % -98.47 % -68.35 %
5Y -90.67 % -87.39 % -2.46 % 240.34 % -69.24 % 0.00 % -95.47 % -98.16 % -99.20 % -68.35 %
10Y 1 486.00 % -87.39 % -90.73 % -74.80 % -69.24 % 0.00 % -86.62 % -98.07 % -99.85 % -68.35 %
From the beginning 1 486.00 % -87.39 % -97.01 % -68.13 % -69.24 % 0.00 % -99.25 % -98.07 % -99.89 % -68.35 %

Dividend

Merrimack Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Third Harmonic Bio, Inc.